Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Cardiol Angeiol (Paris) ; 72(4): 101610, 2023 Oct.
Article in French | MEDLINE | ID: mdl-37300904

ABSTRACT

Peripartum cardiomyopathy is a life-threatening condition that requires urgent diagnosis and management. Bromocriptine was established as disease specific therapy; less data is known about Cabergolin which is another prolactin secretion inhibitor. In this paper we report 4 peripartum cardiomyopathy cases treated successfully with Cabergoline, including a cardiogenic shock case requiring mechanical circulatory support.


Subject(s)
Cardiomyopathies , Peripartum Period , Humans , Cabergoline/therapeutic use , Shock, Cardiogenic/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...